Genome Engineering allows the easy manipulation of genomes down to the nucleotide level.

The role of proteins that are central to RAD51 loading in homologous recombination are also important in the protection of stalled replication forks from degradation by nucleases. Many of these act to promote RAD51 accumulation on single-stranded DNA that

Join our webinar to learn how we fine-tune the semiconductor-based target enrichment to improve the capture of the most challenging regions with hybridization kits fit dsDNA/ssDNA probes.

Target identification in solid tumors can help enable therapeutic development against indications of high unmet need and across a wide patient population.

The SARS-CoV-2 pandemic necessitated the rapid development of high-quality monoclonal antibodies (mAbs) for therapeutic, diagnostic, and vaccine development.

Neoantigen based immuno-oncology therapies are proving promising, but neoantigen identification and production are bottlenecks to boosting efficacy.

Engineering protein disaggregases to counter the protein misfolding that underpins neurodegeneration

If you are struggling with low capture efficiency or high cost to produce your customized panel in targeted sequencing, please come to this FREE webinar to learn about our semiconductor DNA synthesis technologyused for target enrichment, which gives high

The COVID-19 pandemic has caused great devastation throughout the world, and effective solutions to clinically detect the virus are urgently needed. While the qRT-PCR method is useful for detecting the presence of SARS-CoV-2 virus in people, it is useful

Inhibitors of immune-checkpoint proteins, such as PD1, PD-L1, VISTA, Tim3 and Lag3, have indicated broad and diverse opportunities to increase antitumor immunity by enhancing T cell activity with the potential to produce durable clinical responses.